| Issue | Title | |
| Vol 15, No 2 (2008) | Biochemotherapy for the Treatment of Metastatic Malignant Melanoma: A Clinical Practice Guideline | Abstract PDF |
| Denise Stys-Norman | ||
| Vol 23, No 5 (2016) | Bioelectrical impedance phase angle as a prognostic indicator of survival in head-and-neck cancer | Abstract PDF HTML |
| M.S. Wladysiuk, R. Mlak, K. Morshed, W. Surtel, A. Brzozowska, T. Małecka-Massalska | ||
| Vol 21, No 4 (2014) | Biologic, psychological, and social health needs in cancer care: how far have we come? | Abstract PDF HTML |
| F. Schulte | ||
| Vol 13, No 1 (2006) | Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma | Details PDF |
| Lara J Williams, Duane L Guernsey, Alan G Casson | ||
| Vol 19 (2012): Personalized Medicine in Metastatic NSCLC: a Canadian Perspective | Biomarkers that currently affect clinical practice: EGFR, ALK, MET, KRAS | Abstract PDF HTML |
| M.D. Vincent, M.S. Kuruvilla, N.B. Leighl, S. Kamel-Reid | ||
| Vol 27, No 1 (2020) | Biopsy on progression in patients with EGFR mutation–positive advanced non-small-cell lung cancer—a Canadian experience | Abstract PDF HTML |
| Q. Chu, A. Agha, N. Devost, R. N. Walton, S. Ghosh, C. Ho | ||
| Vol 16, No 6 (2009) | Bogarting that joint might decrease oral HPV among cannabis users | Abstract PDF |
| S. Zwenger | ||
| Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective | Bone health in nonmetastatic prostate cancer: what’s the big deal? | Abstract PDF |
| J.B. Lattouf, F. Saad | ||
| Vol 19, No 5 (2012) | Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art | Abstract PDF HTML |
| M. Clemons, K.A. Gelmon, K.I. Pritchard, A.H.G. Paterson | ||
| Vol 17, No 4 (2010) | BONUS 5: 5th Annual Bone and The Oncologist New Updates | Abstract PDF |
| N. Bouganim, E. Amir, M. Clemons | ||
| Vol 23, No 5 (2016) | Book review: Balanced Ethics Review: A Guide for Institutional Review Board Members | Abstract PDF HTML |
| T. Christie | ||
| Vol 23, No 1 (2016) | Book review: Hypnotic Approaches in Cancer and Palliative Care | Abstract PDF HTML |
| G. Giddings | ||
| Vol 22, No 3 (2015) | Book review: Therapeutic Revolution: The History of Medical Oncology From Early Days to the Creation of the Subspecialty | Abstract PDF HTML |
| C.I. Falkson | ||
| Vol 22, No 3 (2015) | Book review: Therapeutic Revolution: The History of Medical Oncology From Early Days to the Creation of the Subspecialty | Abstract PDF HTML |
| G. Giddings | ||
| Vol 22, No 3 (2015) | Book review: Therapeutic Revolution: The History of Medical Oncology From Early Days to the Creation of the Subspecialty | Abstract PDF HTML |
| J. Ragaz, S. Shakeraneh | ||
| Vol 13, No 5 (2006) | Bortezomib in Multiple Myeloma and Lymphoma: A systematic review and clinical practice guideline | Details PDF |
| Christopher A Smith | ||
| Vol 21, No 4 (2014) | Bortezomib in multiple myeloma: systematic review and clinical considerations | Abstract PDF HTML |
| T.C. Kouroukis, F.G. Baldassarre, A.E. Haynes, K. Imrie, D.E. Reece, M.C. Cheung | ||
| Vol 21, No 6 (2014) | BRAF mutation correlates with recurrent papillary thyroid carcinoma in Chinese patients | Abstract PDF HTML |
| W.Y. Fang, L. Ye, X.F. Zhang, L.Y. Shen, R.L. Han, Q. Wei, X.C. Fei, X. Chen, W.Q. Wang, S. Wang, G. Ning | ||
| Vol 26, No 3 (2019) | Brain cancer survival in Canada 1996–2008: effects of sociodemographic characteristics | Abstract PDF HTML |
| E. V. Walker, J. Ross, Y. Yuan, T. R. Smith, F. G. Davis | ||
| Vol 16, No 1 (2009) | Brain Metastases from Unknown Primary or Primary Brain Tumor: A Diagnostic Dilemma | Details PDF |
| Sarah Campos, Philip Davey, Amanda Hird, Bryn Pressnail, Juan Bilbao, Richard Aviv, Sean Symons, Farhad Pirouzmand, Emily Sinclair, Shaelyn Culleton, Eric deSa, Philiz Goh, Edward Chow | ||
| Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist | Brain metastases in non-small-cell lung cancer: are tyrosine kinase inhibitors and checkpoint inhibitors now viable options? | Abstract PDF HTML |
| S. Morin-Ben Abdallah, A. Wong | ||
| Vol 22, No 4 (2015) | BRCA1/2 population screening: embracing the benefits | Abstract PDF HTML |
| S.E. Plon | ||
| Vol 18, No 1 (2011) | Breaking new ground in a new year | Details PDF HTML |
| M. McLean | ||
| Vol 21, No 5 (2014) | Breast and cervical cancer screening behaviours among colorectal cancer survivors in Nova Scotia | Abstract PDF HTML |
| M. Corkum, R. Urquhart, G. Kephart, J.A. Hayden, G. Porter | ||
| Vol 24, No 5 (2017) | Breast cancer and dermatomyositis: a case study and literature review | Abstract PDF HTML |
| E. Hendren, O. Vinik, H. Faragalla, R. Haq | ||
| Vol 20, No 1 (2013) | Breast cancer and the environment: what is left to learn? | Details PDF HTML |
| S. Narod | ||
| Vol 20, No 5 (2013) | Breast cancer and the environment: why research and preventive action are needed | Abstract PDF HTML |
| J.T. Brophy, M.M. Keith, R. Park, A. Watterson, M. Gilbertson, R. DeMatteo | ||
| Vol 22, No 5 (2015) | Breast cancer screening panels continue to confuse the facts and inject their own biases | Abstract PDF HTML |
| D.B. Kopans | ||
| Vol 26, No 6 (2019) | Breast cancer screening policy—good science should trump bad politics | Abstract PDF HTML |
| M. J. Yaffe | ||
| Vol 20, No 2 (2013) | Breast cancer survivorship and South Asian Women: understanding about the follow-up care plan and perspectives and preferences for information post treatment | Abstract PDF HTML |
| S. Singh-Carlson, F. Wong, L. Martin, S.K.A. Nguyen | ||
| Vol 24, No 3 (2017) | Breast magnetic resonance imaging: are those who need it getting it? | Abstract PDF HTML |
| S. Tan, J. David, L. Lalonde, M. El Khoury, M. Labelle, R. Younan, E. Patocskai, J. Richard, I. Trop | ||
| Vol 26, No 1 (2019) | Brigatinib is another treatment option for patients diagnosed with advanced ALK-positive non-small-cell lung cancer who are treatment-naïve or who have progressed on or are intolerant to crizotinib | Abstract PDF HTML |
| B. Melosky, P. Cheema, G. Liu | ||
| 2008: Presentations from the Integrating Wellness into Cancer Care Conference | Bringing wellness back into health care: the role of social networks | Abstract PPT Presentation |
| Alex R. Jadad | ||
| Vol 14, No 6 (2007) | Broad funding for oxaliplatin in Ontario | Details PDF |
| Derek J Jonker | ||
| Vol 24, No 3 (2017) | Budget impact analysis of a breast rapid diagnostic unit | Abstract PDF HTML |
| M. Elmi, H. Hussain, S. Nofech-Mozes, B. Curpen, A. Leahey, N. Look Hong | ||
| Vol 25, No 6 (2018) | Building an oncology community of practice to improve cancer care | Abstract PDF HTML |
| W. Fingrut, L. A. Beck, D. Lo | ||
| Vol 26, No 1 (2019) | Building capacity in cancer knowledge translation through catalyst grants | Abstract PDF HTML |
| M. A. O'Brien, E. Grunfeld | ||
| Vol 23, No 6 (2016) | Burden of illness for metastatic melanoma in Canada, 2011–2013 | Abstract PDF HTML |
| D.S. Ernst, T. Petrella, A.M. Joshua, A. Hamou, M. Thabane, S. Vantyghem, F. Gwadry-Sridhar | ||
| Vol 23, No 2 (2016) | But other than mesothelioma? An estimate of the proportion of work-related cancers in Quebec | Abstract PDF HTML |
| F. Labrèche, P. Duguay, A. Boucher, R. Arcand | ||
| Vol 27, No 1 (2020) | Can concordance between actual care received and a pathway map be measured on a population level in Ontario? A pilot study | Abstract PDF HTML |
| K. Forster, K. Tsang, S. Li, L. Ieraci, P. Murray, K. J. Woltman, D. Chmelnitsky, C. M.B. Holloway, E. D. Kennedy | ||
| Vol 26 (2019): Advances in Colorectal Cancer: Translating Best Evidence to Practice | Can less be more? Organ preservation strategies in the management of rectal cancer | Abstract PDF HTML |
| F. Rouleau-Fournier, C. J. Brown | ||
| Vol 21, No 2 (2014) | Can oncologists predict survival for patients with progressive disease after standard chemotherapies? | Abstract PDF HTML |
| T.K. Taniyama, K. Hashimoto, N. Kastumata, A. Hirakawa, K. Yonemori, M. Yunokawa, C. Shimizu, K. Tamura, M. Ando, Y. Fujiwara | ||
| Vol 23, No 3 (2016) | Can the referring surgeon enhance accrual of breast cancer patients to medical and radiation oncology trials? The ENHANCE study | Abstract PDF HTML |
| A. Arnaout, I. Kuchuk, N. Bouganim, G. Pond, S. Verma, R. Segal, S. Dent, S. Gertler, X. Song, F. Kanji, M. Clemons | ||
| Vol 22, No 2 (2015) | Canadian cancer screening disparities: a recent historical perspective | Abstract PDF HTML |
| J. Kerner, J. Liu, K. Wang, S. Fung, C. Landry, G. Lockwood, L. Zitzelsberger, V. Mai | ||
| Vol 18, No 5 (2011) | Canadian College of Medical Geneticists guidelines for the indications, analysis, and reporting of cancer specimens | Abstract PDF HTML |
| A. J. Dawson, J. McGowan-Jordan, J. Chernos, J. Xu, J. Lavoie, J.-C. Wang, M. R. Steinraths, S. Shetty | ||
| Vol 22, No 2 (2015) | Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 1: prophylaxis | Abstract PDF HTML |
| J.C. Easaw, M.A. Shea-Budgell, C.M.J. Wu, P.M. Czaykowski, J. Kassis, B. Kuehl, H.J. Lim, M. MacNeil, D. Martinusen, P.A. McFarlane, E. Meek, O. Moodley, S. Shivakumar, V. Tagalakis, S. Welch, P. Kavan | ||
| Vol 22, No 2 (2015) | Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment | Abstract PDF HTML |
| J.C. Easaw, M.A. Shea-Budgell, C.M.J. Wu, P.M. Czaykowski, J. Kassis, B. Kuehl, H.J. Lim, M. MacNeil, D. Martinusen, P.A. McFarlane, E. Meek, O. Moodley, S. Shivakumar, V. Tagalakis, S. Welch, P. Kavan | ||
| Vol 23, No 3 (2016) | Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancer | Abstract PDF HTML |
| B. Melosky, J. Agulnik, R. Albadine, S. Banerji, D.G. Bebb, D. Bethune, N. Blais, C. Butts, P. Cheema, P. Cheung, V. Cohen, J. Deschenes, D.N. Ionescu, R. Juergens, S. Kamel-Reid, S.A. Laurie, G. Liu, W. Morzycki, M.S. Tsao, Z. Xu, V. Hirsh | ||
| Vol 26, No 1 (2019) | Canadian consensus: oligoprogressive, pseudoprogressive, and oligometastatic non-small-cell lung cancer | Abstract PDF HTML |
| S. A. Laurie, S. Banerji, N. Blais, S. Brule, P. K. Cheema, P. Cheung, N. Daaboul, D. Hao, V. Hirsh, R. Juergens, J. Laskin, N. Leighl, R. MacRae, G. Nicholas, D. Roberge, J. Rothenstein, D. J. Stewart, M. S. Tsao | ||
| Vol 25, No 5 (2018) | Canadian evidence-based guideline for the first-line treatment of chronic lymphocytic leukemia | Abstract PDF HTML Supplemental Material |
| C. Owen, A. S. Gerrie, V. Banerji, S. Assouline, C. Chen, K. S. Robinson, E. Lye, G. Fraser | ||
| Vol 18, No 4 (2011) | Canadian Expert Group consensus recommendations: KRAS testing in colorectal cancer | Abstract PDF HTML |
| F. Aubin, S. Gill, R. Burkes, B. Colwell, S. Kamel–Reid, S. Koski, A. Pollett, B. Samson, M. Tehfe, R. Wong, S. Young, D. Soulieres | ||
| Vol 18, No 3 (2011) | Canadian initiatives for locally advanced breast cancer research and treatment: inaugural meeting of the Canadian Consortium for LABC | Abstract PDF HTML |
| M. Brackstone, A. Robidoux, S. Chia, J. Mackey, R. Dent, J. F. Boileau, M. Clemons | ||
| Vol 20, No 4 (2013) | Canadian integrative oncology research priorities: results of a consensus-building process | Abstract PDF HTML |
| L.C. Weeks, D. Seely, L.G. Balneaves, H.S. Boon, A. Leis, D. Oneschuk, S.M. Sagar, M.J. Verhoef | ||
| Vol 24, No 4 (2017) | Canadian Lung Cancer Conference 2017 | Abstract PDF HTML |
| N. Chooback, B. Melosky, C. Ho | ||
| Vol 25, No 3 (2018) | Canadian Lung Cancer Conference 2018 | Abstract PDF HTML |
| S. Lau, Y. Wang, C. Ho, B. Melosky | ||
| Vol 26, No 4 (2019) | Canadian Lung Cancer Conference 2019 | Abstract PDF HTML |
| A. Pender, E. M. Dunne, S. K. Wong, C. Ho, B. Melosky | ||
| Vol 25, No 5 (2018) | Canadian perspectives: update on inhibition of ALK-positive tumours in advanced non-small-cell lung cancer | Abstract PDF HTML |
| B. Melosky, P. Cheema, J. Agulnik, R. Albadine, D. G. Bebb, N. Blais, R. Burkes, C. Butts, P. B. Card, A.M Y. Chan, V. Hirsh, D. N. Ionescu, R Juergens, W. Morzycki, Z. Poonja, R. Sangha, M. Tehfe, M. S. Tao, M. Vincent, Z. Xu, G. Liu | ||
| Vol 23, No 2 (2016) | Canadian recommendations for the management of breakthrough cancer pain | Abstract PDF HTML |
| P. Daeninck, B. Gagnon, R. Gallagher, J.D. Henderson, Y. Shir, C. Zimmermann, B. Lapointe | ||
| Vol 14, No 3 (2007) | Canadian Recommendations for the Treatment of Glioblastoma Multiforme | Details PDF |
| Warren Mason | ||
| Vol 18, No 3 (2011) | Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme | Abstract PDF HTML |
| J. C. Easaw, W. P. Mason, J. Perry, N. Laperrière, D. D. Eisenstat, R. Del Maestro, K. Bélanger, D. Fulton, D. Macdonald | ||
| Vol 14, No 5 (2007) | Canadian Supportive Care Recommendations for the Management of Anemia in Patients with Cancer | Details PDF |
| Joseph Mikhael, Barbara Melosky, Christine Cripps, Daniel Rayson, Tom Kouroukis | ||
| Vol 15, No 1 (2008) | Canadian Supportive Care Recommendations for the Management of Neutropenia in Patients with Cancer | Abstract PDF |
| C. Tom Kouroukis, Joseph Mikhael, Sunil Verma, Stephen Chia, Christine Desbiens, Danny Robson, Christine Cripps | ||
| Vol 20, No 1 (2013) | Canadian trends in liver cancer: a brief clinical and epidemiologic overview | Abstract PDF HTML |
| P. De, D. Dryer, M.C. Otterstatter, R. Semenciw | ||
| Vol 15, No 6 (2008) | CANCER AND THROMBOSIS: RECENT ADVANCES | Abstract PDF |
| Susan Solymoss | ||
| Vol 21, No 3 (2014) | Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management | Abstract PDF HTML |
| E. Donnellan, B. Kevane, B.R. Healey Bird, F. Ni Ainle | ||
| Vol 14, No 5 (2007) | Cancer Antigen 125 in Ovarian Cancer Surveillance: A Decision Analysis Model | Details PDF |
| Laura Hopkins, Doug Coyle, Tien Le, Michael Fung Kee Fung, George Wells | ||
| Vol 22, No 3 (2015) | Cancer care burden: aiming at the Achilles heel | Abstract PDF HTML |
| S. Ahmed, R.K. Shahid, K. Gesy | ||
| Vol 23, No 6 (2016) | Cancer care in South India: perspectives from visiting Canadian oncologists | Abstract PDF HTML |
| S. Karim, J.C. Del Paggio, S.R. Berry, C.M. Booth | ||
| Vol 19, No 1 (2012) | Cancer control: life and death in an unequal world | Abstract PDF HTML |
| S. B. Sutcliffe | ||
| Vol 16, No 6 (2009) | Cancer diagnostic assessment programs: standards for the organization of care in Ontario | Abstract PDF |
| T. Oliver, M. Brouwers, J. Crawford, P. Ellison, W. Evans, A. Gagliardi, J. Lacourciere, V. Mai, S. McNair, T. Minuk, l. Radeneck, C. Rand, J. Ross, D. Lo, J. Smylie, J. Srigley, H. Stern, M. Trudeau | ||
| Vol 23, No 1 (2016) | Cancer Evolution–Development: experience of hepatitis B virus–induced hepatocarcinogenesis | Abstract PDF HTML |
| W.B. Liu, J.F. Wu, Y. Du, G.W. Cao | ||
| Vol 23, No 4 (2016) | Cancer incidence, mortality, and stage at diagnosis in First Nations living in Manitoba | Abstract PDF HTML |
| K.M. Decker, E.V. Kliewer, A.A. Demers, K. Fradette, N. Biswanger, G. Musto, B. Elias, D. Turner | ||
| 2008: Presentations from the Integrating Wellness into Cancer Care Conference | CANCER IS A WORD NOT A SENTENCE | Abstract PPT Presentation |
| Robert Buckman | ||
| Vol 20, No 2 (2013) | Cancer Narratives: Words Beyond Disease A Call for Submissions | Details PDF HTML |
| D. Rayson | ||
| Vol 15, No 3 (2008) | Cancer Nutrition and Rehabilitation – Its Time has Come! | Abstract PDF |
| Martin R. Chasen | ||
| Vol 17, No 6 (2010) | Cancer nutrition rehabilitation program: the role of social work | Abstract PDF |
| D. Townsend, C. Accurso–Massana, C. Lechman, S. Duder, M. Chasen | ||
| Vol 23, No 6 (2016) | Cancer referral and treatment activity 2010–2015: a population-based study from Vancouver Island | Abstract PDF HTML |
| P. Savage, C. Holloway, G. Lindsay, K. Shubrook, C. Jones, M. Fung, K. Schaff, H. Anderson, K. Nystedt, J. Rauw | ||
| Vol 18, No 6 (2011) | Cancer risk: are we well behaved? | Abstract PDF HTML |
| A. G. Cramp, L. Fitzgeorge, H. Prapavessis | ||
| Vol 12, No 4 (2005) | Cancer Stem Cells Revisited | Details PDF |
| Richard J Ablin, Brian L. Pipes | ||
| Vol 14, No 3 (2007) | Cancer Symptom Control Trials: How May We Advance This Field? | Details PDF |
| Neil MacDonald | ||
| Aromatase Inhibitor Supplement, 2007 | Cancer Therapy Disparity— Unequal Access to Breast Cancer Therapeutics and Drug Funding in Canada | Details PDF |
| Sunil Verma, Sandeep Sehdev, Anil Abraham Joy | ||
| Going Beyond Efficacy | Cancer Treatment Related Bone Loss | Abstract PDF |
| Aliya Khan, Nazir Khan | ||
| Going Beyond Efficacy | Cancer-Associated Thrombosis: Prevention and Treatment | Details PDF |
| Agnes Lee, Kelsey Brose | ||
| Vol 23 (2016): Use of Cannabinoids in Cancer Care | Cannabis and cancer: towards a new understanding | Abstract PDF HTML |
| M.A. Ware | ||
| Vol 26, No 4 (2019) | Cannabis use in cancer: a survey of the current state at BC Cancer before recreational legalization in Canada | Abstract PDF HTML |
| P. Hawley, M. Gobbo | ||
| Vol 27, No 1 (2020) | CanPROS Scientific Conference 2019 Oral Abstracts | Abstract PDF HTML |
| Various Authors | ||
| Vol 27, No 1 (2020) | CanPROS Scientific Conference 2019 Poster Abstracts | Abstract PDF HTML |
| Various Authors | ||
| Vol 18, No 2 (2011) | Capecitabine or infusional 5-fluorouracil for gastroesophageal cancer: a cost–consequence analysis | Abstract PDF HTML |
| A. M. Horgan, J. J. Knox, G. Liu, C. Sahi, P. A. Bradbury, N B. Leighl | ||
| Vol 17, No 1 (2010) | Capecitabine-induced cardiotoxicity: case report and review of the literature | Abstract PDF |
| C. Ang, M. Kornbluth, M.P. Thirlwell, R.D. Rajan | ||
| Vol 24, No 3 (2017) | Carcinoma ex pleomorphic adenoma: case report and options for systemic therapy | Abstract PDF HTML |
| N. Chooback, Y. Shen, M. Jones, K. Kasaian, M. Martin, T. Ng, T. Thompson, M. Marra, J. Laskin, C. Ho | ||
| Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective | Cardiac and cognitive effects of androgen deprivation therapy: are they real? | Abstract PDF |
| S. M.H. Alibhai, H. Z. Mohamedali | ||
| Vol 15, No 1 (2008) | Cardiac Management During Adjuvant Trastuzumab Therapy: Recommendations of the Canadian Trastuzumab Working Group | Abstract PDF |
| John Mackey, Mark Clemons, Sunil Verma, Diego Delgado, Susan Dent, Alexander Paterson, Louise Provencher, Michael Sawyer, Marc Andre Cote | ||
| Vol 18, No 5 (2011) | Caring for survivors of breast cancer: perspective of the primary care physician | Abstract PDF HTML |
| S. L. Smith, E. S. Wai, C. Alexander, S. Singh-Carlson | ||
| Vol 20, No 2 (2013) | Case report of very late gastric cancer recurrence | Abstract PDF HTML |
| P. Blanchette, J.H. Lipton, D. Barth, H. Mackay | ||
| Vol 19, No 3 (2012) | Casting stones and casting aspersions: let’s not lose sight of the main issues in the euthanasia debate | Abstract PDF HTML |
| Jose Pereira | ||
| Vol 19, No 3 (2012) | Caught in the middle: case study of a brachial (sentry) lymph node recurrence after resection and locoregional breast radiotherapy | Abstract PDF HTML |
| G. Lee, M. Clemons, J. Cho, G.J. Czarnota, R. Dinniwell | ||
| Vol 22, No 5 (2015) | Causes of death and subsequent treatment after initial radical or palliative therapy of stage III non-small-cell lung cancer | Abstract PDF HTML |
| A.G. Robinson, K. Young, K. Balchin, A. Ashworth, T. Owen | ||
| Vol 17, No 4 (2010) | Cetuximab in locally advanced head-and-neck cancer: defining the population | Abstract PDF |
| C. Ho | ||
| Vol 15, No 4 (2008) | Cetuximab Treatment in a Patient with Metastatic Colorectal Cancer and Psoriasis | Details PDF |
| Bart Neyns, Vanessa Meert, Frederik Vandenbroucke | ||
| Vol 24, No 2 (2017) | Challenges and insights in implementing coordinated care between oncology and primary care providers: a Canadian perspective | Abstract PDF HTML |
| J.R. Tomasone, M. Vukmirovic, M.C. Brouwers, E. Grunfeld, R. Urquhart, M.A. O’Brien, M. Walker, F. Webster, M. Fitch | ||
| 201 - 300 of 1728 Items | << < 1 2 3 4 5 6 7 8 9 10 > >> | |
User
Current Oncology is published by:
Endorsed publication of the Canadian Association of Medical Oncologists (CAMO)
